Detection of Local Relapse of Prostate Cancer With 18F-PSMA-1007

被引：9

作者：

Seifert, Robert ^{[1
]}

Schafigh, Darius ^{[2
]}

Boegemann, Martin ^{[3
]}

Weckesser, Matthias ^{[1
]}

Rahbar, Kambiz ^{[1
]}

机构：

[1] Univ Hosp Munster, Dept Nucl Med, Albert Schweitzer Campus 1,Bldg A1, D-48149 Munster, Germany

[2] Univ Hosp Munster, Dept Clin Radiol, Munster, Germany

[3] Univ Hosp Munster, Dept Urol, Munster, Germany

来源：

CLINICAL NUCLEAR MEDICINE | 2019年 / 44卷 / 06期

关键词：

PSMA PET/CT; prostate cancer; local relapse; PSMA;

D O I：

10.1097/RLU.0000000000002543

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Prostate-specific membrane antigen (PSMA)-targeted PET/CT has become a fundamental tool in the management of patients with prostate cancer, especially to rule out local recurrence after surgery or radiation. However, the assessment of the prostatic fossa is difficult due to the renal excretion of PSMA-targeted radionuclides. PET/CT studies using Ga-68-PSMA-11 PET/CT and F-18-PSMA-1007 of a 61-year-old man after radical prostatectomy are presented. This case illustrates that F-18-PSMA-1007 is an ideal radionuclide for the detection of local recurrence of prostate cancer and is superior to Ga-68-PSMA-11, especially in case of pelvic lesions.

引用

页码：E394 / E395

页数：2

共 50 条

[21] Asymptomatic Prostate Cancer Metastasis in Rectal Mucosa Revealed by 18F-PSMA-1007 PET/CT
Wang, Shu
Cheng, Zhiming
Du, Bulin
Li, Yaming
Li, Xuena
CLINICAL NUCLEAR MEDICINE, 2023, 48 (04) : 354 - 355
[22] Dual-tracer PET/CT for lung and prostate cancer: 18F-FDG and 18F-PSMA-1007
Li, Haijun
Li, Lifeng
Peng, Dechang
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
[23] Rib Fractures Mimicking Bone Metastases in 18F-PSMA-1007 PET/CT for Prostate Cancer
Panagiotidis, Emmanouil
Paschali, Anna
Giannoula, Evanthia
Chatzipavlidou, Vasiliki
CLINICAL NUCLEAR MEDICINE, 2019, 44 (01) : E46 - E48
[24] 18F-PSMA-1007 PET/CT Detects Micrometastases in a Patient With Biochemically Recurrent Prostate Cancer
Giesel, Frederik L.
Kesch, Claudia
Yun, Mijin
Cardinale, Jens
Haberkorn, Uwe
Kopka, Klaus
Kratochwil, Clemens
Hadaschik, Boris A.
CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : E497 - E499
[25] 18F-PSMA-1007 PET in Biochemical Recurrent Prostate Cancer: An Updated Meta-Analysis
Ferrari, Matteo
Treglia, Giorgio
CONTRAST MEDIA & MOLECULAR IMAGING, 2021, 2021
[26] Diagnostic value of 18F-PSMA-1007 PET/CT for predicting the pathological grade of prostate cancer
Niu, Xiao-Bo
Li, Yan-Peng
Wang, Jun
Mei, Xiao-Li
Zhao, Xue-Yan
Liu, Ting-Ting
Xu, Sha-Sha
Han, Xing-Min
Cheng, Jing-Liang
CANCER BIOLOGY & THERAPY, 2024, 25 (01)
[27] Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer
Rahbar, Kambiz
Afshar-Oromieh, Ali
Seifert, Robert
Wagner, Stefan
Schaefers, Michael
Boegemann, Martin
Weckesser, Matthias
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (12) : 2055 - 2061
[28] Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer
Kambiz Rahbar
Ali Afshar-Oromieh
Robert Seifert
Stefan Wagner
Michael Schäfers
Martin Bögemann
Matthias Weckesser
European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 2055 - 2061
[29] Intraindividual Comparison of 18F-PSMA-1007 with Renally Excreted PSMA Ligands for PSMA PET Imaging in Patients with Relapsed Prostate Cancer
Dietlein, Felix
Kobe, Carsten
Hohberg, Melanie
Zlatopolskiy, Boris D.
Krapf, Philipp
Endepols, Heike
Taeger, Philipp
Hammes, Jochen
Heidenreich, Axel
Persigehl, Thorsten
Neumaier, Bernd
Drzezga, Alexander
Dietlein, Markus
JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (05) : 729 - 734
[30] Intense 18F-PSMA-1007 Uptake of Splenic Hemangioma
Jia, Guorong
Dong, Aisheng
Cheng, Chao
Zuo, Changjing
CLINICAL NUCLEAR MEDICINE, 2024, 49 (02) : e90 - e92

← 1 2 3 4 5 →